Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks

Importance Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. The decision to treat is primarily based on the presence of plus disease, defined as dilation and tortuosity of retinal vessels. However, clinical diagnosis of plus disease is highly subjective and variable. Objective To implement and validate an algorithm based on deep learning to automatically diagnose plus disease from retinal photographs. Design, Setting, and Participants A deep convolutional neural network was trained using a data set of 5511 retinal photographs. Each image was previously assigned a reference standard diagnosis (RSD) based on consensus of image grading by 3 experts and clinical diagnosis by 1 expert (ie, normal, pre–plus disease, or plus disease). The algorithm was evaluated by 5-fold cross-validation and tested on an independent set of 100 images. Images were collected from 8 academic institutions participating in the Imaging and Informatics in ROP (i-ROP) cohort study. The deep learning algorithm was tested against 8 ROP experts, each of whom had more than 10 years of clinical experience and more than 5 peer-reviewed publications about ROP. Data were collected from July 2011 to December 2016. Data were analyzed from December 2016 to September 2017. Exposures A deep learning algorithm trained on retinal photographs. Main Outcomes and Measures Receiver operating characteristic analysis was performed to evaluate performance of the algorithm against the RSD. Quadratic-weighted &kgr; coefficients were calculated for ternary classification (ie, normal, pre–plus disease, and plus disease) to measure agreement with the RSD and 8 independent experts. Results Of the 5511 included retinal photographs, 4535 (82.3%) were graded as normal, 805 (14.6%) as pre–plus disease, and 172 (3.1%) as plus disease, based on the RSD. Mean (SD) area under the receiver operating characteristic curve statistics were 0.94 (0.01) for the diagnosis of normal (vs pre–plus disease or plus disease) and 0.98 (0.01) for the diagnosis of plus disease (vs normal or pre–plus disease). For diagnosis of plus disease in an independent test set of 100 retinal images, the algorithm achieved a sensitivity of 93% with 94% specificity. For detection of pre–plus disease or worse, the sensitivity and specificity were 100% and 94%, respectively. On the same test set, the algorithm achieved a quadratic-weighted &kgr; coefficient of 0.92 compared with the RSD, outperforming 6 of 8 ROP experts. Conclusions and Relevance This fully automated algorithm diagnosed plus disease in ROP with comparable or better accuracy than human experts. This has potential applications in disease detection, monitoring, and prognosis in infants at risk of ROP.

[1]  Lanning B. Kline,et al.  Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1988, Archives of ophthalmology.

[2]  Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. , 1990, Archives of ophthalmology.

[3]  Allen Foster,et al.  Retinopathy of prematurity in middle-income countries , 1997, The Lancet.

[4]  J. Flynn,et al.  Screening for retinopathy of prematurity employing the retcam 120: sensitivity and specificity. , 2001, Archives of ophthalmology.

[5]  Michael T Trese,et al.  Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. , 2002, Archives of ophthalmology.

[6]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[7]  George Hripcsak,et al.  Measuring agreement in medical informatics reliability studies , 2002, J. Biomed. Informatics.

[8]  John Flynn,et al.  Characterization of changes in blood vessel width and tortuosity in retinopathy of prematurity using image analysis , 2002, Medical Image Anal..

[9]  W. Tasman,et al.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. , 2004, Archives of ophthalmology.

[10]  A. Fielder,et al.  Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. , 2003, Archives of ophthalmology.

[11]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[12]  William V Good,et al.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. , 2004, Transactions of the American Ophthalmological Society.

[13]  Anna L. Ells,et al.  The International Classification of Retinopathy of Prematurity revisited. , 2005, Archives of ophthalmology.

[14]  D. Wallace,et al.  A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. , 2007, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[15]  Michael F Chiang,et al.  Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. , 2007, Archives of ophthalmology.

[16]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[17]  Enrico Grisan,et al.  A Novel Method for the Automatic Grading of Retinal Vessel Tortuosity , 2008, IEEE Transactions on Medical Imaging.

[18]  Li Fei-Fei,et al.  ImageNet: A large-scale hierarchical image database , 2009, CVPR.

[19]  R. Enzenauer,et al.  Socioeconomics of retinopathy of prematurity in-hospital care. , 2010, Archives of ophthalmology.

[20]  McDonnell Tj,et al.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. , 2011 .

[21]  Alice Z Chuang,et al.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. , 2011, The New England journal of medicine.

[22]  Training fellows for retinopathy of prematurity care: a Web-based survey. , 2011, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[23]  D. Wallace,et al.  Fellowship training in retinopathy of prematurity. , 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[24]  M. Chiang,et al.  Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity. , 2012, Journal of pediatric ophthalmology and strabismus.

[25]  Michael F Chiang,et al.  Retinopathy of prematurity residency training. , 2012, Ophthalmology.

[26]  D. Kaufman,et al.  Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts. , 2012, JAMA ophthalmology.

[27]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[28]  Yoshua Bengio,et al.  How transferable are features in deep neural networks? , 2014, NIPS.

[29]  Michael F. Chiang,et al.  Development and Evaluation of Reference Standards for Image-based Telemedicine Diagnosis and Clinical Research Studies in Ophthalmology , 2014, AMIA.

[30]  Ursula Schmidt-Erfurth,et al.  Inter-expert and intra-expert agreement on the diagnosis and treatment of retinopathy of prematurity. , 2015, American journal of ophthalmology.

[31]  Daniel L. Rubin,et al.  Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks , 2015, AMIA.

[32]  Sotirios A. Tsaftaris,et al.  Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015 , 2015, Lecture Notes in Computer Science.

[33]  Alejandro F. Frangi,et al.  Medical Image Computing and Computer-Assisted Intervention -- MICCAI 2015 , 2015, Lecture Notes in Computer Science.

[34]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[35]  Ebenezer Daniel,et al.  Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. , 2015, JAMA ophthalmology.

[36]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[37]  Deniz Erdoğmuş,et al.  Computer-Based Image Analysis for Plus Disease Diagnosis in Retinopathy of Prematurity: Performance of the "i-ROP" System and Image Features Associated With Expert Diagnosis. , 2015, Translational vision science & technology.

[38]  Dumitru Erhan,et al.  Going deeper with convolutions , 2014, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[39]  Gabriel J. Brostow,et al.  Automated Retinopathy of Prematurity Case Detection with Convolutional Neural Networks , 2016, LABELS/DLMIA@MICCAI.

[40]  Jaime S. Cardoso,et al.  Deep Learning and Data Labeling for Medical Applications , 2016, Lecture Notes in Computer Science.

[41]  Deniz Erdogmus,et al.  Plus Disease in Retinopathy of Prematurity: A Continuous Spectrum of Vascular Abnormality as a Basis of Diagnostic Variability. , 2016, Ophthalmology.

[42]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[43]  Deniz Erdogmus,et al.  Plus Disease in Retinopathy of Prematurity: Improving Diagnosis by Ranking Disease Severity and Using Quantitative Image Analysis. , 2016, Ophthalmology.

[44]  Deniz Erdogmus,et al.  Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis. , 2016, JAMA ophthalmology.

[45]  Ryan Swan,et al.  Automated Image Quality Assessment for Fundus Images in Retinopathy of Prematurity , 2017, AMIA.

[46]  H. Aerts,et al.  Deep Learning for Fully-Automated Localization and Segmentation of Rectal Cancer on Multiparametric MR , 2017, Scientific Reports.

[47]  E. Finkelstein,et al.  Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes , 2017, JAMA.

[48]  Aaron Y. Lee,et al.  Deep learning is effective for the classification of OCT images of normal versus Age-related Macular Degeneration , 2016, bioRxiv.

[49]  Andrew H. Beck,et al.  Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer , 2017, JAMA.

[50]  Neil J. Joshi,et al.  Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks , 2017, JAMA ophthalmology.

[51]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[52]  Michael V. McConnell,et al.  Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning , 2017, Nature Biomedical Engineering.

[53]  Geoffrey E. Hinton,et al.  Who Said What: Modeling Individual Labelers Improves Classification , 2017, AAAI.

[54]  Daniel S. Kermany,et al.  Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.

[55]  Anna L. Ells,et al.  An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials , 2017, Eye.

[56]  S. Oh,et al.  Deep Learning–Based Prediction of Refractive Error Using Photorefraction Images Captured by a Smartphone: Model Development and Validation Study , 2019, JMIR medical informatics.